However, mesencephalic tissues of patients with PD have greater immunoreactivity for inflammasome components compared to healthy controls, and patients with PD also differ in their ASC and NLRP3 expression when compared to individuals with non-PD nigral cell loss [32]. The gene discussed is NLRP3; the disease is Parkinson disease.